Sebastian G. Bottcher

Warener Str. 7
Berlin, BE 12683, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

[18F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.

[18F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.

Journal: Haematologica

Published: February 03, 2026

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Journal: The New England journal of medicine

Published: December 08, 2025

Long-Term Immune Response to SARS-CoV-2 Vaccination in Hematologic Malignancies: An Update of the ImV-HOng Trial of the East German Study Group for Hematology and Oncology.

Long-Term Immune Response to SARS-CoV-2 Vaccination in Hematologic Malignancies: An Update of the ImV-HOng Trial of the East German Study Group for Hematology and Oncology.

Journal: Cancers

Published: July 17, 2025

Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia.

Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia.

Journal: American journal of hematology

Published: October 31, 2024

Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies.

Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 18, 2024

Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.

Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.

Journal: HemaSphere

Published: September 25, 2024

End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.

End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 30, 2024

Comparison between five pattern-based approaches for automated diagnostic classification of mature/peripheral B-cell neoplasms based on standardized EuroFlow flow cytometry immunophenotypic data.

Comparison between five pattern-based approaches for automated diagnostic classification of mature/peripheral B-cell neoplasms based on standardized EuroFlow flow cytometry immunophenotypic data.

Journal: Computers in biology and medicine

Published: August 26, 2024

Effects of epileptic seizures on the quality of biosignals recorded from wearables.

Effects of epileptic seizures on the quality of biosignals recorded from wearables.

Journal: Epilepsia

Published: June 04, 2024

The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG).

The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG).

Journal: HemaSphere

Published: May 14, 2024

Nerve injuries due to fractures in childhood : Primarily and secondarily on the upper extremity

Nerve injuries due to fractures in childhood : Primarily and secondarily on the upper extremity

Journal: Unfallchirurgie (Heidelberg, Germany)

Published: February 13, 2024

Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.

Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 18, 2024

Showing 1-12 of 123

Last Updated: 09/26/2026